Managed Healthcare Executive
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations
Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...
UPI
FDA approves non-hormonal medication for menopause symptoms
The U.S. Food and Drug Administration has approved a new non-hormonal treatment to help women manage menopause symptoms such as hot flashes and night sweats. Elinzanetant (Lynkuet), a once-daily pill, ...
Hosted on MSN
FDA approves new nonhormonal menopause drug that targets hot flashes
Women dealing with hot flashes could soon have a new option for relief. The FDA has approved a nonhormonal drug designed to help ease those uncomfortable menopause symptoms. Milei’s Clear-Cut Victory ...
Seattle Times
FDA Approves New Menopause Drug
The Food and Drug Administration approved a new drug Friday for the treatment of hot flashes and night sweats in menopausal women. The drug, Lynkuet, which contains the compound elinzanetant, adds to ...
Medical Xpress
FDA approves nonhormonal drug to ease menopause hot flashes and night sweats
The federal Food and Drug Administration today approved a new menopause drug that reduces hot flashes and night sweats after the drug was successfully tested at UVA Health and other sites in the ...
Reuters
US FDA approves Bayer's menopause relief drug
Oct 24 (Reuters) - The U.S. Food and Drug Administration has approved Bayer's (BAYGn.DE), opens new tab drug to ease hot flashes in menopausal women, the German company said on Friday, a welcome ...
Bloomberg L.P.
Bayer Wins FDA Approval for Menopause Drug Treating Hot Flashes
Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of Lynkuet. The Food and Drug Administration approved the drug — also known by ...
Yahoo
US FDA approves Bayer's menopause relief drug
The logo of Bayer Mexico is pictured at the company's plant in Lerma, Mexico November 10, 2022. REUTERS/Henry Romero (Reuters) -The U.S. Food and Drug Administration has approved Bayer's drug to ease ...
Yahoo
US FDA approves Bayer's menopause relief drug
The logo of Bayer Mexico is pictured at the company's plant in Lerma, Mexico November 10, 2022. REUTERS/Henry Romero (Reuters) -Germany's Bayer said on Friday the U.S. health regulator has approved ...
FiercePharma
With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds
Following a slight delay earlier this year—and a world-first green light in the U.K. over the summer—Bayer has clinched an FDA nod to bolster the limited arsenal of nonhormonal treatments for some of ...
MedCity News
GSK Blood Cancer Drug Returns to the U.S. Market, But New FDA Approval Is Still Limited
GSK finally has the long-awaited FDA approval it sought for blood cancer drug Blenrep. Three years after the pharmaceutical giant pulled the multiple myeloma therapy from the market, the FDA approved ...
Benzinga.com
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep
On Friday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients with ...